Form 8-K - Current report:
SEC Accession No. 0001571049-16-010826
Filing Date
2016-01-19
Accepted
2016-01-19 17:11:00
Documents
2
Period of Report
2016-01-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K t1600172_8k.htm 8-K 15293
2 EXHIBIT 10.1 t1600172_ex10-1.htm EX-10.1 67765
  Complete submission text file 0001571049-16-010826.txt   84506
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36410 | Film No.: 161348976
SIC: 2834 Pharmaceutical Preparations